ARNA Financial Facts

Net loss: -26.81M
Total revenues: 9.18M
See Full Income Statement

Prepaid expenses and other current assets: 4.07M
Other non-current assets: 3.08M
See Full Balance Sheet

Arena Pharmaceuticals, Inc. (ARNA) Earnings

  |   Expand Research on ARNA
Next EPS Date 11/3/15 *Est. EPS Growth Rate -466.7% *Last Qtr.
Average EPS % Beat Rate +20.8% Revenue Growth Rate -28.3% *Last Qtr.
Average % Move 1-Wk after EPS -3.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/5/15 Q215 -$0.11-$0.14 +$0.03$9.18M$10.95M N/A Details
5/11/15 Q115 -$0.10-$0.14 +$0.04$12.3M$10.56M N/A Details
3/2/15 Q414 -$0.15-$0.12 -$0.03$9.2M$10.36M N/A Details
11/3/14 Q314 -$0.05-$0.12 +$0.07$8.2M$10.9M N/A Details
8/1/14 Q214 $0.03-$0.11 +$0.14$12.8M$9.81M N/A Details
5/12/14 Q114 -$0.12-$0.10 -$0.02$6.8M$7.98M N/A Details
2/27/14 Q413 -$0.11-$0.11 $0.00$6.2M$7M N/A Details
11/7/13 Q313 -$0.08-$0.12 +$0.04$3.6M$5.3M N/A Details